GILD
Gilead Sciences, Inc.
Income statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31.0B | 29.4B | 28.8B | 27.1B | 27.3B | 27.3B | 24.7B | 22.4B | 22.1B | 26.1B | 30.4B | 32.6B | 24.9B | 11.2B | 9.7B | 8.4B | 7.9B | 7.0B | 5.3B | 4.2B |
Cost of revenue | 6.22B | 6.23B | 6.25B | 6.50B | 5.66B | 6.60B | 4.57B | 4.68B | 4.85B | 4.37B | 4.26B | 4.01B | 3.79B | 2.86B | 2.47B | 2.12B | 1.87B | 1.60B | 1.13B | 0.77B |
| Gross profit | 24.8B | 23.2B | 22.5B | 20.6B | 21.6B | 20.7B | 20.1B | 17.8B | 17.3B | 21.7B | 26.1B | 28.6B | 21.1B | 8.3B | 7.2B | 6.3B | 6.1B | 5.4B | 4.2B | 3.5B |
| 6.33B | 5.80B | 5.91B | 5.72B | 4.98B | 4.60B | 4.93B | 9.11B | 5.02B | 3.73B | 5.10B | 3.01B | 2.85B | 2.12B | 1.76B | 1.23B | 1.07B | 0.94B | 0.72B | 0.59B | |
| 6.81B | 5.77B | 6.09B | 6.09B | 5.67B | 5.25B | 5.15B | 4.38B | 4.06B | 3.88B | 3.40B | 3.43B | 2.98B | 1.70B | 1.46B | 1.24B | 1.04B | 0.95B | 0.80B | 0.71B | |
Other operating expenses | 14.0B | 1.6B | 8.8B | 1.2B | 3.6B | 939M | 6.0B | — | — | — | — | — | — | — | — | — | — | — | 11M | — |
| Operating income | −2.4B | 10.0B | 1.7B | 7.6B | 7.3B | 9.9B | 4.1B | 4.3B | 8.2B | 14.1B | 17.6B | 22.2B | 15.3B | 4.5B | 4.0B | 3.8B | 4.0B | 3.5B | 2.7B | 2.2B |
Non-operating income | −0.17B | −0.23B | −0.97B | −0.75B | −1.52B | −1.64B | −2.40B | 0.87B | −0.40B | −0.60B | −0.54B | −0.53B | −0.41B | −0.32B | −0.40B | −0.14B | −49M | −27M | −5.8M | 47M |
| Pretax income | −2.5B | 9.8B | 690M | 6.9B | 5.8B | 8.3B | 1.7B | 5.2B | 7.8B | 13.5B | 17.1B | 21.7B | 14.9B | 4.2B | 3.6B | 3.7B | 3.9B | 3.5B | 2.7B | 2.2B |
Taxes | 1.33B | 1.29B | 0.21B | 1.19B | 1.22B | 2.05B | 1.55B | −0.23B | 2.34B | 8.90B | 3.60B | 3.55B | 2.76B | 1.13B | 1.02B | 0.85B | 1.01B | 0.87B | 0.69B | 0.63B |
| Net income | −3.9B | 8.5B | 480M | 5.7B | 4.6B | 6.2B | 123M | 5.4B | 5.5B | 4.6B | 13.5B | 18.1B | 12.1B | 3.1B | 2.6B | 2.8B | 2.9B | 2.6B | 2.0B | 1.6B |
| Diluted EPS | −3.16 | 6.78 | 0.38 | 4.50 | 3.64 | 4.93 | 0.10 | 4.22 | 4.17 | 3.51 | 9.94 | 11.91 | 7.35 | 1.81 | 1.64 | 1.77 | 1.66 | 1.41 | 1.03 | 0.82 |
| Diluted shares | — | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.28B | 1.31B | 1.32B | 1.36B | 1.52B | 1.65B | 1.70B | 1.58B | 1.58B | 1.75B | 1.87B | 1.92B | 1.93B |
| Revenue growth | — | +2.4% | +6.0% | −0.6% | −0.1% | +10.6% | +10.0% | +1.5% | −15.2% | −14.1% | −6.9% | +31.1% | +122.2% | +15.5% | +15.7% | +5.5% | +13.4% | +31.4% | +26.1% | — |
| Gross margin | 79.9% | 78.8% | 78.3% | 76.0% | 79.3% | 75.8% | 81.5% | 79.2% | 78.1% | 83.3% | 86.0% | 87.7% | 84.8% | 74.5% | 74.5% | 74.7% | 76.5% | 77.2% | 78.9% | 81.8% |
| Operating margin | −7.6% | 34.0% | 5.8% | 28.0% | 26.9% | 36.3% | 16.5% | 19.1% | 37.1% | 54.1% | 58.0% | 68.0% | 61.3% | 40.4% | 41.3% | 45.2% | 49.8% | 50.3% | 50.2% | 51.2% |
| Net margin | −12.5% | 28.9% | 1.7% | 20.9% | 16.8% | 22.8% | 0.5% | 24.0% | 24.7% | 17.7% | 44.4% | 55.5% | 48.6% | 27.5% | 26.7% | 33.4% | 36.5% | 37.6% | 37.1% | 37.5% |